2815520-86-4
2815520-86-4
Chemical Structure
Oseltamivir-d5 phosphate
Synonym(s): GS 4104-d5 phosphate
- CAS No.: 2815520-86-4
- Formula:C16H26D5N2O8P
- Molecular Weight:415.43
IUPAC Name: ethyl-d5 (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate phosphate
InChIKey: PGZUMBJQJWIWGJ-DPDNDPGGSA-N
SMILES: N[C@H]1CC(C(OC(C([2H])([2H])[2H])([2H])[2H])=O)=C[C@H]([C@@H]1NC(C)=O)OC(CC)CC.O=P(O)(O)O
Biological Activity: Oseltamivir-d5 (phosphate) is the deuterium labeled Oseltamivir phosphate. Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Oseltamivir-d5 phosphate | Oseltamivir-d5 (phosphate) is the deuterium labeled Oseltamivir phosphate. Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oseltamivir phosphate (Standard) | ≥98% | Oseltamivir (phosphate) (Standard) is the analytical standard of Oseltamivir (phosphate). This product is intended for research and analytical applications. Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oseltamivir-d3 phosphate | Oseltamivir-d3 (phosphate)eis the deuterium labeled Oseltamivir phosphate. Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oseltamivir-13C,d3 phosphate | Oseltamivir-13C,d3 (phosphate) (GS 4104-13C,d3 (phosphate)) is 13C labeled Oseltamivir (phosphate). Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Oseltamivir phosphate | 99.93% | Oseltamivir phosphate (GS 4104) is a neuraminidase inhibitor recommended for the treatment and prophylaxis of influenza A and B. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Huang H, et al. Transplacental transfer of Oseltamivir phosphate and its metabolite Oseltamivir carboxylate using the ex vivo human placenta perfusion model in Chinese Hans population. J Matern Fetal Neonatal Med. 2016 Aug 8:1-5. [Content Brief]
